Latest News

  • Redefining Remission: Proteins and Genes Working Together

    Diagnostics World | Contributed Commentary  Many times genes alone do not provide the information necessary to get a full picture of what’s currently happening in the body. With this in mind, scientists are becoming increasingly interested in the study of protein biomarkers.  

    Aug 30, 2016
  • Theranos Halts New Zika Test After FDA Inspection

    WSJ | Theranos, led by Elizabeth Holmes, withdraws request for approval of blood test for Zika virus after FDA found problems with patient safeguards.

    Aug 31, 2016
  • News and Notes in Diagnostics August 2016

    Diagnostics World Briefs  News from Invitae, Repositive, Princeton University, and more. Sophia Genetics , global leader in Data-Driven Medicine, and Devyser , pioneer in diagnostic kits for complex DNA testing, announce today the signing of a new partnership to simplify the adoption of Next-Generation DNA Sequenc

    Aug 30, 2016
  • The Steve Jobs Of Drawing Blood

    Forbes | The concept from a company called Velano Vascular repurposes the IV most hospital patients already have in their arms so blood can be drawn without having their veins repeatedly stuck by needles.

    Aug 29, 2016
  • FDA Clears First-Of-Their Kind Tests To Help Identify Concussions

    Forbes | Currently, there's no easy test to diagnose a concussion. The FDA just approved two computerized tests to help doctors spot these injuries.

    Aug 25, 2016
  • BioNano, Berry Plan New Structural Variation Instrument, Assays for Clinical Use

    Diagnostics World | BioNano Genomics has announced that its Irys platform for detecting genomic structural variations will serve as the foundation for a new system and assays developed with Berry Genomics for which Berry will seek Chinese Food and Drug Administration (CFDA) regulatory approval for a number of clinical indications in China.

    Aug 19, 2016
  • Genetic Tests for a Heart Disorder Mistakenly Find Blacks at Risk

    The New York Times | A study finds that errors were made because earlier research linking genetic traits to illness did not include enough blacks.

    Aug 18, 2016
  • Proove Releases Predictive Pharmacogenetic Tests for Addiction, Fibromyalgia, Thromboembolism

    Diagnostics World | Proove Biosciences has added three new tests to its line of genetic profiles that help physicians make better decisions about how to treat illnesses. The new profiles for addiction, fibromyalgia, and thromboembolism are designed to identify specific genetic markers and other factors that are unique to each patient and influence that patient's response to different treatments. Physicians in private, university, and public healthcare centers can use this information to make more informed decisions regarding treatment on an individual basis.

    Aug 15, 2016
  • Speeding Diagnosis for Newborns with Liver Disease

    Diagnostics World | Doctors at Baylor College of Medicine and Texas Children’s Hospital report a way to detect biliary atresia and other neonatal liver diseases in newborns with a blood test.

    Aug 10, 2016
  • Big Driver of Medicare Spending Doctors Doing More Tests in Their Offices

    WSJ | Government Medicare payouts rise when new medical devices allow doctors to test patients in their own offices, the latest data show.

    Aug 10, 2016
  • Quest Diagnostics Introduces Digital Cognitive Assessment Tool

    News Medical | The new CogniSense tool from Quest Diagnostics, available as an iPad app, provides standard tests for assessing patients with dementia, in a format that can be tracked over time and integrated into electronic medical records.

    Aug 9, 2016
  • Zoetis Purchases Lab-on-Chip Company for Veterinary Diagnostics

    Diagnostics World News Brief | Zoetis, a veterinary medicine company, has acquired Denmark-based Scandinavian Micro Biodevices in an $80 million deal to develop new point-of-care diagnostic devices for use with pets and livestock.

    Aug 8, 2016
  • Bristol-Myers Squibbs Defeat Is A Victory For Personalized Medicine

    Forbes | Bristol-Myers Squibb Company stock price fell 16% after its breakthrough cancer drug, Opdivo, failed to slow tumor growth in previously untreated patients with non-small cell lung cancer. The reason why may be a diagnostic test.

    Aug 6, 2016
  • Why The World Needs An Essential Diagnostics List

    Forbes | Without diagnostics, medicine is blind. And yet, diagnostics receive much less attention than vaccines and drugs.

    Aug 5, 2016
  • Diagnostics at Home: Mately Uses Blood Spots to Track STDs

    Diagnostics World | Healthcare innovation is connecting with patients in ways that are easily accessible, low cost, and convenient. Mately is doing that via a new, at-home, sexually transmitted disease (STD) screening system.

    Aug 4, 2016
  • Foundation Medicine Announces FDA, CMS Parallel Review

    Diagnostics World Brief | Foundation Medicine announced that the U.S. Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS) have accepted FoundationOne for Parallel Review as an innovative technology most likely to benefit from the efficiencies of this program. The FDA also accepted Foundation Medicine’s request for review as part of its Expedited Access Pathway (EAP) for breakthrough devices.

    Aug 2, 2016
  • Theranos Presents Data On New Blood Test Machine Remains Mum On Previous Technology

    Forbes | Elizabeth Holmes, the company's charismatic founder and chief executive, will show scientists details of a new device called the miniLab system, as well as results for tests done with it, but the data presented have no direct bearing on the tests that got Theranos in hot water with regulators.

    Aug 1, 2016
  • Theranos' Hail Mary Pass A Tabletop Laboratory

    CNN | CEO Elizabeth Homes will speak this afternoon at the American Association for Clinical Chemistry conference, and is expected to unveil a new product that promises to miniaturize lab analysis.

    Aug 1, 2016